Figure 5 | Scientific Reports

Figure 5

From: CD163+ immune cell infiltrates and presence of CD54+ microvessels are prognostic markers for patients with embryonal rhabdomyosarcoma

Figure 5

(a) Comparison of CD34 positive microvessels in RMS subtypes, RMA and RME. (b) Shows the correlation between CD34 positive microvessels and CD8 (left panel) or CD68 (right panel) infiltrating cells in RMS. (c) Comparison of CD31 positive microvessels and (d) CD54 positive microvessels in RMA and RME tumors. (e) Shows a correlation analysis of CD31 and CD54 positive microvessels in RMS. In (f) a sequential staining of CD31 and CD54 was performed for RMA and RME tumors. For each subtype a representative staining is shown; magnification – 100x. (a), (c) and (d) display the mean values with the respective standard error of the mean; RMA – alveolar Rhabdomyosarcoma; RME – embryonal Rhabdomyosarcoma, *p < 0.05, ** 0.05 > p > 0.01, *** 0.01 > p > 0.005, ****p < 0.005.

Back to article page